Sandbox Reserved 1322

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (19:40, 27 February 2018) (edit) (undo)
 
(2 intermediate revisions not shown.)
Line 6: Line 6:
== Function ==
== Function ==
-
 
+
Acetylcholine is an excitatory neurotransmitter that acts in both the central nervous system and the peripheral nervous system. Acetylcholine is released in motor neurons and causes muscles to be activated. Lobeline by itself can either activate or inhibit nicotinic acetylcholine receptors in the both CNS and PNS. Acetylcholine Binding Protein, on the other hand, binds acetylcholine, modulating its transmission through ligand-gated ion channels. Combined with Lobeline, this can cause a significant decrease in the activity of acetylcholine receptors by inhibiting receptor activity while also modulating transmission through such receptors.
-
Lobeline by itself can either activate or inhibit nicotinic acetylcholine receptors in the both CNS and PNS. Acetylcholine Binding Protein, on the other hand, binds acetylcholine, modulating its transmission through ligand-gated ion channels. Combined with Lobeline, this can cause a significant decrease in the activity of acetylcholine receptors by inhibiting receptor activity while also modulating transmission through such receptors.
+
== Disease ==
== Disease ==
Line 13: Line 12:
The protein is associated with the α7-nicotinic acetylcholine receptor, which is associated with neurodegenerative effects in Alzheimer's Disease and Schizophrenia. Possible pharmaceuticals targeting the α7-nicotinic acetylcholine receptor involving the α7-acetylcholine binding protein and lobeline complex could be developed, which would have particular signficance in their ability to mediate ion channels without affecting neurotransmitter release.
The protein is associated with the α7-nicotinic acetylcholine receptor, which is associated with neurodegenerative effects in Alzheimer's Disease and Schizophrenia. Possible pharmaceuticals targeting the α7-nicotinic acetylcholine receptor involving the α7-acetylcholine binding protein and lobeline complex could be developed, which would have particular signficance in their ability to mediate ion channels without affecting neurotransmitter release.
Lobeline by itself is sold as a smoking aid due to its activity blocking the uptake of nicotine and its subsequent binding to nicotinic acetylcholine receptors.
Lobeline by itself is sold as a smoking aid due to its activity blocking the uptake of nicotine and its subsequent binding to nicotinic acetylcholine receptors.
- 
-
== Relevance ==
 
== Structural highlights ==
== Structural highlights ==
Line 22: Line 19:
</StructureSection>
</StructureSection>
== References ==
== References ==
 +
https://www.ncbi.nlm.nih.gov/books/NBK11143/
 +
https://www.ncbi.nlm.nih.gov/pubmed/29237730
<references/>
<references/>

Current revision

This Sandbox is Reserved from January through July 31, 2018 for use in the course HLSC322: Principles of Genetics and Genomics taught by Genevieve Houston-Ludlam at the University of Maryland, College Park, USA. This reservation includes Sandbox Reserved 1311 through Sandbox Reserved 1430.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Humanized Acetylcholine Binding Protein and Lobeline Complex

Caption for this structure

Drag the structure with the mouse to rotate

References

https://www.ncbi.nlm.nih.gov/books/NBK11143/ https://www.ncbi.nlm.nih.gov/pubmed/29237730

Personal tools